2023 clinical immunization safety assessment (CISA) base IDIQ

Active Awarded Last action

Contract number
75D30123D18241
Awardee
Awarding agency
Task orders
4 $6,304,190 obligated

Award facts

Opportunity
  • 75D30123R72840 Solicitation number
Combined order value
  • $6,312,020 Current, with exercised options
  • $6,556,828 Potential, with all options
Last date to order 62% complete
IDV ceiling 7% used
$86,008,000.12
Maximum order
$86,008,000.12
Award type
Multiple award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The CDC Pittsburgh awarded an indefinite-delivery contract to Duke University with a ceiling of $86,008,000.12 on September 26, 2023, under the 2023 Clinical Immunization Safety Assessment (CISA) base IDIQ. This is a multiple-award vehicle with no set-aside designation. Performance occurs at Durham, North Carolina. The IDIQ supports clinical vaccine safety evaluation, immunization safety assessment research, and customer information technology services under Executive Order 14398, with an ultimate completion date of September 25, 2028.

Recent delivery orders issued under this IDIQ include a September 2024 order for the CISA RSV Infants Study (lead site) with a ceiling of $1,541,816.17, a September 2023 order for clinical vaccine safety evaluation and customer information technology support with a ceiling of $947,243, and a September 2023 order for clinical research and immunization safety assessment services with a ceiling of $2,180,450. All orders are priced on a cost-no-fee basis. Performance for issued orders occurs at Durham, North Carolina 27705. Duke University's Office of Research Administration executes the work through self-performed delivery, leveraging the institution's established capacity in pediatric clinical trials, vaccine evaluation, and infectious disease research infrastructure.

Task orders

Task order Ordering agency Obligated Awarded
Cisa home laiv study- lead site, EO 14398 75D30126F00004 CDC Pittsburgh $1,869,870
Cisa RSV infants study (lead site) 75D30124F00003 CDC Pittsburgh $1,532,778
2023 clinical immunization safety assessment (CISA) base IDIQ 75D30123F00001 CDC Pittsburgh $730,242
2023 clinical immunization safety assessment (CISA) base IDIQ 75D30123F00002 CDC Pittsburgh $2,171,300

Transactions

Action Obligated Date
Other Administrative Action P00001 · EO 14398 $0
Original award $0

Quick answers

Who was awarded contract 75D30123D18241?

75D30123D18241 was awarded to Duke University by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 26, 2023.

How much is contract 75D30123D18241 worth?

Orders under 75D30123D18241 have obligated $6,304,190. Their combined current value, with exercised options, is $6,312,020. Their combined potential value, with all options, is $6,556,828. 75D30123D18241's own ceiling is $86,008,000. A single order can be worth up to $86,008,000.

How many orders have been placed under contract 75D30123D18241?

4 orders have been placed under 75D30123D18241, the latest on September 25, 2026.

Who can order from contract 75D30123D18241?

75D30123D18241 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75D30123D18241 part of a contract vehicle?

Yes. 75D30123D18241 is part of Clinical Immunization Safety Assessment 2023 - 2028 (CISA).

Was contract 75D30123D18241 competed?

The extent of competition for 75D30123D18241 was full and open competition. The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV